By Alufisha Fischer
Malawi has joined the rest of the world in commemorating World AIDS Day today, celebrating gains in its HIV response but also warning that hard-won progress could be undermined by looming global funding cuts.
According to the 2024 national progress report, Malawi has achieved the global 95-95-95 targets ahead of the 2025 deadline.
The country reports that 95% of people living with HIV know their status, 95% of those are on antiretroviral therapy (ART), and 95% of patients on treatment have achieved viral suppression.
Earlier, National AIDS Commission (NAC) Chief Executive Officer Dr Beatrice Matanje told #MBCDigital that Malawi’s success reflects strong political commitment, community-led action, and sustained support from both domestic and international partners.
Dr Matenje noted that adult HIV prevalence has continued its long-term decline, falling from more than 14% in the late 1990s to 7% in 2024.
She also highlighted major reductions in AIDS-related deaths, which dropped from a peak of 80,000 in 2003 to 14,000 last year.
However, she raised concern over slow progress in paediatric treatment, with only 58% of HIV-positive children aged 0–14 currently on ART.
Looking ahead, Malawi is preparing for the arrival of Lenacapavir, a twice-yearly injectable HIV prevention and treatment drug expected to reach the country in early 2026 through the PEPFAR programme.
But these gains are at risk. Malawi’s HIV response relies heavily on support from PEPFAR and the Global Fund, both of which are facing budget pressures and aid reductions.
This year’s day is focused on encouraging men to get tested for HIV, as it is the group which is most reluctant to know their HIV status.
